ABSTRACT
Bronchial thermoplasty was recently approved for treating severe refractory asthma that is not well controlled by high-dose inhaled corticosteroids and long-acting bronchodilator therapy. This article reviews its indications, evidence of efficacy, and protocols.
Footnotes
↵* Dr. Gildea and Dr. Castro have conducted research (ie, the AIR2 trial) that was funded by Asthmatx.
- Copyright © 2011 The Cleveland Clinic Foundation. All Rights Reserved.
View Abstract
